Table 2.
Univariate analysis | Multivariate analysis | |||||
---|---|---|---|---|---|---|
OR | 95%CI | P-value | OR | 95%CI | P-value | |
Male | 1.9 | 0.7–5.3 | 0.17 | |||
Age | 0.9 | 0.9–1.0 | 0.02 | 0.9 | 0.9–1.0 | 0.01 |
Apical ballooning | 1.3 | 0.5–3.2 | 0.50 | |||
Atrial fibrillation | 2.5 | 0.9–6.6 | 0.05 | 2.2 | 0.6–8.6 | 0.22 |
Life-threatening arrhythmia | 11.3 | 2.3–54.1 | <0.01 | 7.3 | 1.2–43.7 | 0.03 |
EF ≤ 35% | 3.8 | 1.7–8.4 | <0.01 | 3.9 | 1.5–10.1 | <0.01 |
DM Typ II | 0.9 | 0.4–2.4 | 0.98 | |||
GFR < 60 ml/min | 1.0 | 0.4–2.4 | 0.91 | |||
History of cancer | 1.3 | 0.4–3.7 | 0.64 | |||
QTc | 1.0 | 0.9–1.0 | 0.08 | 0.9 | 0.9–1.0 | 0.31 |
HR, hazard ratio; EF, ejection fraction; CRP, c-reactive protein; GFR, glomerular filtration rate.